Under construction – not a live service
Sign in
CompletedNo phase

Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA

Key facts

Who runs it
Soren Overgaard
Where
Denmark36 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
20,000 people enrolled
Started
1 Sept 2022
Ended
1 Sept 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Antibiotic dosage practice
Record updated
8 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • All patients receiving a primary Total Hip Arthroplasty (THA) due to primary and secondary causes of osteoarthritis

Who cannot take part

  • Patients receiving a primary THA due to either acute or sequelae of proximal femoral or acetabular fractures
  • Patients receiving a primary THA due to bone tumor or metastasis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Aim: To compare the effect of one single dose versus multiple doses of prophylactic antibiotics administered within 24 hours, on the development of PJI in patients with osteoarthritis undergoing primary THA.

Read full original descriptionShow less

The study is designed as a cross-over, cluster randomized, non-inferiority trial. All Danish orthopedic surgery departments performing primary THA with the majority being within inclusion criteria will be involved: Based on national quality databases, two-year cohorts of approximately 20,000 primary THAs conducted at all public and private orthopedic departments in Denmark, this includes 36 sites corresponding to a total of 39 departments.

The 2 groups in the trial

  • Treatment A, Single-dose practiceTreatment being tested

    One preoperative single dose of either Dicloxacillin/Cloxacillin 2g OR Cefuroxime 1.5g administered intravenously prior to surgical incision. As the study is a non-inferiority trial, we have chosen the Experimental design category.

    Treatment: Antibiotic dosage practice

  • Treatment B, Multiple-dose practiceExisting treatment, for comparison

    One preoperative dose of either Dicloxacillin/Cloxacillin 2g OR Cefuroxime 1.5g administered intravenously prior to surgical incision followed by 3 postoperative doses of Dicloxacillin/Cloxacillin 1g x 3 OR Cefuroxime 750mg x 3 within 24 hours after the preoperative dose.

    Treatment: Antibiotic dosage practice

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With Osteoarthritis: A Cross-over, Cluster Randomized Controlled, Non-inferiority Trial Based on National Quality Databases. ProHipQ-OA
Record updated
8 July 2026